Whittier Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $615K | Sell |
6,459
-25
| -0.4% | -$2.09K | 0.01% | 458 |
|
|
2026
Q1 | $526K | Buy |
6,484
+775
| +14% | +$63.9K | 0.01% | 436 |
|
|
2025
Q4 | $490K | Sell |
5,709
-2,789
| -33% | -$229K | 0.01% | 444 |
|
|
2025
Q3 | $655K | Sell |
8,498
-8
| -0.1% | -$625 | 0.01% | 404 |
|
|
2025
Q2 | $665K | Sell |
8,506
-914
| -10% | -$68.2K | 0.01% | 452 |
|
|
2025
Q1 | $683K | Hold |
9,420
| – | – | 0.01% | 436 |
|
|
2024
Q4 | $697K | Buy |
9,420
+13
| +0.1% | +$910 | 0.01% | 439 |
|
|
2024
Q3 | $621K | Sell |
9,407
-261
| -3% | -$19K | 0.01% | 462 |
|
|
2024
Q2 | $893K | Buy |
9,668
+42
| +0.4% | +$3.72K | 0.01% | 382 |
|
|
2024
Q1 | $920K | Sell |
9,626
-180
| -2% | -$15.1K | 0.01% | 374 |
|
|
2023
Q4 | $748K | Sell |
9,806
-245
| -2% | -$17K | 0.01% | 407 |
|
|
2023
Q3 | $696K | Sell |
10,051
-2,020
| -17% | -$162K | 0.01% | 403 |
|
|
2023
Q2 | $1.14M | Sell |
12,071
-180
| -1% | -$15.6K | 0.02% | 332 |
|
|
2023
Q1 | $1.01M | Sell |
12,251
-30
| -0.2% | -$2.36K | 0.02% | 351 |
|
|
2022
Q4 | $916K | Sell |
12,281
-1,653
| -12% | -$127K | 0.02% | 370 |
|
|
2022
Q3 | $1.15M | Buy |
13,934
+7,979
| +134% | +$768K | 0.02% | 315 |
|
|
2022
Q2 | $566K | Buy |
5,955
+1,230
| +26% | +$127K | 0.01% | 440 |
|
|
2022
Q1 | $556K | Sell |
4,725
-152
| -3% | -$17.1K | 0.01% | 472 |
|
|
2021
Q4 | $632K | Buy |
4,877
+3,102
| +175% | +$362K | 0.01% | 443 |
|
|
2021
Q3 | $201K | Buy |
+1,775
| New | +$203K | ﹤0.01% | 639 |
|
|
2021
Q2 | – | Sell |
-1,536
| Closed | -$128K | – | 1531 |
|
|
2021
Q1 | $128K | Sell |
1,536
-78
| -5% | -$6.59K | ﹤0.01% | 724 |
|
|
2020
Q4 | $147K | Buy |
1,614
+990
| +159% | +$82.1K | ﹤0.01% | 648 |
|
|
2020
Q3 | $50K | Hold |
624
| – | – | ﹤0.01% | 828 |
|
|
2020
Q2 | $43K | Sell |
624
-315
| -34% | -$22.4K | ﹤0.01% | 820 |
|
|
2020
Q1 | $59K | Buy |
939
+30
| +3% | +$2.16K | ﹤0.01% | 768 |
|
|
2019
Q4 | $71K | Buy |
909
+549
| +153% | +$42.9K | ﹤0.01% | 767 |
|
|
2019
Q3 | $26K | Hold |
360
| – | – | ﹤0.01% | 970 |
|
|
2019
Q2 | $22K | Hold |
360
| – | – | ﹤0.01% | 940 |
|
|
2019
Q1 | $23K | Hold |
360
| – | – | ﹤0.01% | 922 |
|
|
2018
Q4 | $18K | Hold |
360
| – | – | ﹤0.01% | 975 |
|
|
2018
Q3 | $21K | Hold |
360
| – | – | ﹤0.01% | 937 |
|
|
2018
Q2 | $17K | Hold |
360
| – | – | ﹤0.01% | 953 |
|
|
2018
Q1 | $17K | Hold |
360
| – | – | ﹤0.01% | 969 |
|
|
2017
Q4 | $14K | Hold |
360
| – | – | ﹤0.01% | 983 |
|
|
2017
Q3 | $13K | Hold |
360
| – | – | ﹤0.01% | 981 |
|
|
2017
Q2 | $14K | Sell |
360
-270
| -43% | -$9.86K | ﹤0.01% | 938 |
|
|
2017
Q1 | $20K | Buy |
630
+270
| +75% | +$8.45K | ﹤0.01% | 888 |
|
|
2016
Q4 | $11K | Hold |
360
| – | – | ﹤0.01% | 956 |
|
|
2016
Q3 | $14K | Hold |
360
| – | – | ﹤0.01% | 929 |
|
|
2016
Q2 | $12K | Hold |
360
| – | – | ﹤0.01% | 956 |
|
|
2016
Q1 | $11K | Hold |
360
| – | – | ﹤0.01% | 957 |
|
|
2015
Q4 | $9K | Hold |
360
| – | – | ﹤0.01% | 971 |
|
|
2015
Q3 | $9K | Hold |
360
| – | – | ﹤0.01% | 969 |
|
|
2015
Q2 | $9K | Hold |
360
| – | – | ﹤0.01% | 1022 |
|
|
2015
Q1 | $9K | Hold |
360
| – | – | ﹤0.01% | 1028 |
|
|
2014
Q4 | $8K | Hold |
360
| – | – | ﹤0.01% | 902 |
|
|
2014
Q3 | $6K | Hold |
360
| – | – | ﹤0.01% | 917 |
|
|
2014
Q2 | $5K | Hold |
360
| – | – | ﹤0.01% | 935 |
|
|
2014
Q1 | $4K | Hold |
360
| – | – | ﹤0.01% | 972 |
|
|
2013
Q4 | $4K | Hold |
360
| – | – | ﹤0.01% | 976 |
|
|
2013
Q3 | $4K | Hold |
360
| – | – | ﹤0.01% | 983 |
|
|
2013
Q2 | $4K | Buy |
+360
| New | +$4.26K | ﹤0.01% | 987 |
|
Other funds holding EW
Whittier Trust's EW Position: Q2 2026 in Review
Whittier Trust reduced its Edwards Lifesciences (EW) stake by 0.39% in Q2 2026, selling an estimated $2.09K and leaving 6,459 shares worth $615K. The position accounts for 0.01% of the portfolio, ranked #458.
Whittier Trust first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.15M in Q3 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Whittier Trust held 6,459 shares of Edwards Lifesciences worth $615K as of Q2 2026.
- Whittier Trust sold 25 Edwards Lifesciences shares in Q2 2026, an estimated $2.09K.
- Edwards Lifesciences made up 0.01% of Whittier Trust's portfolio in Q2 2026, its #458 holding.
- Whittier Trust first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Whittier Trust's Edwards Lifesciences position peaked at $1.15M in Q3 2022.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.